Synthesis and oral antitumor activity of tetrakis(carboxylato)platinum(IV) complexes

Journal of Medicinal Chemistry

Volumn 43, Issue 7, 2000, Pages 1409-1412

  Lee, Young A ^a   Lee, Sung Sil ^a   Kim, Kwan Mook ^a   Lee, Chong Ock ^a   Sohn, Youn Soo ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM COMPLEX; TETRAKIS(PROPIONATO)PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; LIPOPHILICITY; MOUSE; NONHUMAN; TUMOR XENOGRAFT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; ORGANOPLATINUM COMPOUNDS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS;

EID: 0342748699     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9904250     Document Type: Article

References (17)

1. William, S. D.; Einhorn, L. H. In Cisplatin: Current Status and New Developments; Academic Press: New York, 1980.
2. Rosenberg, B. Anticancer Activity of cis-Dichlorodiammineplatinum(II) and Some Relevant Chemistry. Cancer Treat. Rep. 1979, 53, 1433-1438.
3. Brady, H. R.; Zeidel, M. L.; Kone, B. C. Giebisch, G.; Ullans, S. R. Differential Actions of Cisplatin on Renal Proximal Tubule and Inner Medullary Collecting Duct Cells. J. Pharm. Exp. Ther. 1993, 265, 1421-1428.
4. Thompson, S. W.; Davis, L. E.; Kornfeld, M.; Hilgers, R. D.; Standefer, J. C. Cisplatin Neuropathy. Clinical, Electrophysiologic, Morphologic, and Toxicologic Studies. Cancer 1984, 54, 1269-1275.
5. Giandomenico, C. M.; Abrams, M. J.; Murrer, B. A.; Vollano, J. F.; Rheinheimer, M. I.; Wyer, S. B.; Bossard, G. E.; Higgins, J. D., III. Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entrée into Orally Active Platinum(IV) Antitumor Agents, Inorg. Chem. 1995, 34, 1015-1021.
6. Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Murrer, B. A.; Harrap, K. R. Preclinical Antitumor Evalution of Bis-acetato-ammine-dichloro-cyclohexylamine Platinum(IV): an Orally Active Platinum Drug. Cancer Res. 1993, 53, 2581-2586.
7. 2], a Metabolite of an Orally Active Platinum Anticancer Drug. J. Am. Chem. Soc. 1992, 114, 5646-5654.
8. (b) Gibbons, G. R.; Wyrick, S.; Chaney, S. G. Rapid Reduction of Tetrachloro(D,L-tras)1,2-diaminocyclohexaneplatinum(IV) (Tetraplatin) in RPMI 1640 Tissue Culture Medium. Cancer Res. 1989, 49, 1402-1407.
9. Choi, S.; Mahalingaiah, S.; Delaney, S.; Neale, N. R.; Masood, S. Substitution and Reduction of Platinum(IV) Complexes by a Nucleotide, Guanosine 5′-Monophosphate. Inorg. Chem. 1999, 38, 1800-1805.
10. Yoshida, M.; Khokhar, A. R.; Siddik, Z. H. Axial Ligands and Alicyclic Ring Size Modulate the Activity and Biochemical Pharmacology of Ammine/Cycloalkylamine-Platinum(IV) Complexes in Tumor Cells Resistant to cis-Diamminedichloroplatonim(II) or trans-1R,2R-1S,2S-Diaminocyclohexanetetrachloroplatinum(IV). Cancer Res. 1994, 54, 4691-4697.
11. Ellis, L. T.; Er, H. M.; Hambley, T. W. The Influence of the Axial Ligands of a Series of Platinum(IV) Anti-Cancer Complexes on their Reduction to Platinum(II) and Reaction with DNA. Aust. J. Chem. 1995, 48, 793-806.
12. Kim, K. M.; Lee, Y.-A.; Lee, S. S.; Sohn, Y. S. Facile Synthesis and Structural Properties of (Diamine)tetracarboxylatoplatinum-(IV) Complexes, Inorg. Chim. Acta 1999, 292, 52-56.
13. Lippert, B. Cisplatin. In the Development of Orally Active Platinum Drugs; Kelland, L. R., Ed.; Wiley-VCH: Weinheim, 1999; pp 497-521.
14. Roat, R. M.; Jerardi, M. J.; Kopay, C. B.; Heath, D. C.; Clark, J. A.; DeMars, J. A.; Weaver, J. M.; Bezemer, E.; Reedijk, J. Platinum(II) Complexes Catalyze Reaction between Platinum-(IV) Complexes and 9-Methylxanthine. J. Chem. Soc., Dalton Trans. 1997, 3615-3621.
15. 3]Cl), with Purine Nucleosides and Nucleotides Results in Formation of Platinum-(II) as well as Platinum(IV) Complexes. J. Inorg. Biochem. 1993, 52, 263-274.
16. Barnard, C. F. J.; Vollano, J. F.; Chaloner, P. A.; Dewa, S. Z. Studies on the Oral Anticancer Drug JM216: Synthesis and Characterization of Isomers and Related Complexes. Inorg. Chem. 1996, 35, 3280-3284.
17. Sohn, Y. S.; Back, H.; Cho, Y. H.; Lee, Y.-A; Jung, O.-S.; Lee, C. O.; Kim, Y. S. Synthesis and Antitumor Activity of Novel Polyphosphazene-(diamine)platinum(II) Conjugates. Int. J. Pharm. 1997, 153, 79-91.